
Why GLP-1s have turned fiber-maxxing into a snacking strategy
As GLP-1 drugs suppress hunger and compress eating occasions, fiber is emerging as a way to make smaller snacks feel functional, tolerable and worth the calories
News & Analysis on Food & Beverage Development & Technology

As GLP-1 drugs suppress hunger and compress eating occasions, fiber is emerging as a way to make smaller snacks feel functional, tolerable and worth the calories

After years of acquisitions and declining sales, the health-focused food company is narrowing its portfolio and using the proceeds to shore up its balance sheet

From megamergers to shocking splits, Big Food is reshaping itself at breakneck speed. So, who’s next?

Leadership shake‑up at Barry Callebaut reveals deeper strategic tensions at the world’s biggest chocolate maker

Functional foods are often ultra-processed – but can they be clean label?

In 2026, longevity – not hype – is the real differentiator

Soup-to-Nuts Podcast
As protein demand rises and consumers grow choosier, Good Food Institute Founder Bruce Friedrich outlines how plant-based and cultivated meat can move beyond hype and become investable, scalable industries

It’s hoped EFSA’s proposed limits will offer clarity for manufacturers and regulators alike

Reports around GLP-1 drugs’ potential links to the illness have spurred regulators into action

The GLP‑1 boom is rewriting consumer behaviour at speed and forcing food makers to rethink everything from portion size to product strategy

Although admitting it’s a risk, Oatly is addressing the UPF issue head-on